Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on June 16, 2026 by admin

Using Fenfluramine to Test the Serotonin Deficiency Theory of Depression

Conditions: Depression – Major Depressive Disorder

Interventions: Drug: Fenfluramine Hydrochloride; Radiation: [11C]Cimbi-36; Drug: Placebo

Sponsors: Imperial College Healthcare NHS Trust; University of Oxford

Not yet recruiting
CategoriesClinicalTrials.gov TagsDepression, Healthcare provider, Mood and emotional regulation, News Approved, Social and attachment drive, United Kingdom

Post navigation

Previous PostPrevious Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients
Next PostNext Artificial Intelligence Powered Digital Education Based on the Neuman Systems Model for Breast Cancer Patients Receiving Radiotherap
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.